Latest News about TAK
Recent news which mentions TAK
2 Incredibly Cheap High-Yield Dividend Stocks to Buy Now
February 28, 2023
From Motley Fool
Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients
February 21, 2023
From Benzinga
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
From Motley Fool
Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged
February 02, 2023
From Benzinga
7 Sorry Dividend Stocks to Sell in February Before It’s Too Late
January 30, 2023
From InvestorPlace
Finch Therapeutics Halts Work On Its Only Clinical Stage Asset, Cuts 95% Of Workforce
January 24, 2023
From Benzinga
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
From Benzinga
From Benzinga
From Benzinga
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
From Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
From Benzinga
From Motley Fool
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
From Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
From Benzinga
Why Puma Biotechnology's Shares Jumped 20% on Monday
November 21, 2022
From Motley Fool
Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings
November 17, 2022
From Benzinga
From Motley Fool
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
November 02, 2022
From Motley Fool
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
From Benzinga
Earnings Scheduled For October 27, 2022
October 27, 2022
From Benzinga
7 Dividend Stocks to Sell Pronto Before a Painful Downturn
October 24, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
From Benzinga
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
October 19, 2022
From Motley Fool
From Benzinga
3 IPO Stocks That You Want to Own
September 25, 2022
From Motley Fool
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
September 21, 2022
From Benzinga
Got $5,000? These 2 Dividend Stocks Haven't Been This Cheap in Years
September 14, 2022
From Motley Fool
7 Stocks Under $15 to Buy and Hold Forever
September 01, 2022
From InvestorPlace
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.